Career history of Lynn Connolly
Former positions of Lynn Connolly
| Companies | Position | Start | End |
|---|---|---|---|
| INVIVYD, INC. | Chief Tech/Sci/R&D Officer | 30/06/2020 | 24/03/2022 |
| VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 28/02/2018 | 30/06/2020 |
| ACHAOGEN | Chief Tech/Sci/R&D Officer | 31/12/2015 | 31/12/2016 |
Training of Lynn Connolly
| University of California, Berkeley | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| INVIVYD, INC. | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Lynn Connolly
- Experience
